In this regard, many patients and families are not able to manage hypoglycaemia, to control premeal insulin doses and to perform the CHO counting.21 As a result, they tend to administer an insufficient rapid analogue dose with a consequent postprandial hyperglycaemia. The gene discussed is INS; the disease is Hyperglycemia.